WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H562994
CAS#: 149537-49-5
Description: BPH-651 is a CrtM inhibitor.
Hodoodo Cat#: H562994
Name: BPH-651
CAS#: 149537-49-5
Chemical Formula: C19H21NO
Exact Mass: 279.16
Molecular Weight: 279.380
Elemental Analysis: C, 81.68; H, 7.58; N, 5.01; O, 5.73
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: BPH-651; BPH 651; BPH651; 3 ACW; 3-ACW; 3ACW;
IUPAC/Chemical Name: 3-Biphenyl-4-yl-1-aza-bicyclo[2.2.2]octan-3-ol
InChi Key: WPCQYFUQHBLGAX-UHFFFAOYSA-N
InChi Code: InChI=1S/C19H21NO/c21-19(14-20-12-10-18(19)11-13-20)17-8-6-16(7-9-17)15-4-2-1-3-5-15/h1-9,18,21H,10-14H2
SMILES Code: OC1(C2=CC=C(C3=CC=CC=C3)C=C2)CN4CCC1CC4
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 279.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Lin FY, Liu YL, Li K, Cao R, Zhu W, Axelson J, Pang R, Oldfield E. Head-to-head prenyl tranferases: anti-infective drug targets. J Med Chem. 2012 May 10;55(9):4367-72. doi: 10.1021/jm300208p. Epub 2012 May 1. PubMed PMID: 22486710; PubMed Central PMCID: PMC3349777.